Non-AIDS-defining cancers in people living with HIV
- PMID: 34478666
- DOI: 10.1016/S1470-2045(21)00384-3
Non-AIDS-defining cancers in people living with HIV
Conflict of interest statement
J-PS has received consultant or advisory role fees or meeting invitations from Roche, Merck Sharp & Dohme, Bristol Myers Squibb, Lilly, AstraZeneca, Daiichi-Sankyo, Mylan, Novartis, Pfizer, Pierre Fabre Oncology, LeoPharma, and Gilead; and a grant from MSDAvenir. JC has received research funding or grant support for clinical trials from AstraZeneca, Pfizer, Novartis, and AbbVie; and consultancy or advisory board fees from AstraZeneca, Boehringer Ingelheim, Bristol Myers Squibb, Pfizer, Sanofi, Jansen, Merck Sharp & Dohme, Novartis, Roche, and Takeda. All other authors declare no competing interests.
Comment on
-
The effect of non-AIDS-defining cancers on people living with HIV.Lancet Oncol. 2021 Jun;22(6):e240-e253. doi: 10.1016/S1470-2045(21)00137-6. Lancet Oncol. 2021. PMID: 34087151 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
